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Abstract 34 
 35 
Bifidobacterium spp. typical of the human intestinal microbiota are believed to influence the 36 
balance of immune responses in the intestinal mucosa. 37 
Aim: To investigate the effect of different bifidobacterial species and mixtures of them in in 38 
vitro experiments with PBMCs and CaCo-2 cells. 39 
Methods: Bifidobacterium adolescentis; Bifidobacterium angulatum; Bifidobacterium breve; 40 
Bifidobacterium catenulatum; Bifidobacterium infantis; Bifidobacterium longum; and two 41 
combinations of these bifidobacteria simulating the species composition found in fecal 42 
samples from breast fed (BF) and formula fed (FF) infants were used. The levels of several 43 
cytokines were measured by  direct stimulation of PBMCs and by stimulation of a Caco-44 
2/PBMCs co-culture with bifidobacteria. Results: B. catenulatum and B. breve were the 45 
strongest enhancers of IFN-γ, production by direct stimulation of PBMCs. B. longum was the 46 
highest inducer of IL-10 and the lowest TNF-α stimulus. In the Caco-2/PBMC system, B. 47 
breve was the highest inducer of IL-8 production by Caco-2 cells; significantly different from 48 
B. infantis, B. adolescentis and the FF mixture (p<0·05). IFN-γ produced by PBMCs 49 
stimulated with the BF mixture (containing 22% B. breve, compared to 7% in FF mixture) 50 
was significantly higher compared to B. adolescentis, B. infantis, and B. longum. B. 51 
adolescentis also inhibited  IFN-γ production compared to FF mixture and B. longum. 52 
Conclusions: The proportion of different Bifidobacterium strains seems to be an important 53 
determinant of the cytokine balance in the simulated intestinal environment studied. B. breve 54 
and the combination of the Bifidobacterium species typically found in the microbiota of 55 
breast-fed infants have shown the most significant effects.  56 
 57 
 58 
 59 
 60 
 61 
___________________________________________________________________________ 62 
Abbreviations : PBMCs,  peripheral blood mononuclear cells; BF, breast fed; FF, formula fed; 63 
IECs, intestinal epithelial cells; MRS agar, de Man Rogosa and Sharpe agar; RPMI-1640 64 
medium, Roswell Park Memorial Institute 1640 medium; EMEM médium, Eagle's minimal 65 
essential médium;  FBS, fetal bovine serum; P/S, penicillin-streptomycin; NAA, non-essential 66 
amino acids; TER, Transepithelial Resistance. 67 
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Introduction 68 
 69 
The intestinal microbiota plays a pivotal role in human health by preventing pathogen 70 
colonization, and shaping and maintaining normal mucosal immunity (1). To preserve this 71 
beneficial relationship, the immune system should remain hypo-responsive to commensal 72 
bacteria (mucosal tolerance) (2,3), but , at the same time, it has to combat pathogenic bacteria 73 
(3). The breakdown of the delicate balance of the intestinal immune responses causes the 74 
development of disease states with bowel inflammation (3). In this context, intestinal epithelial 75 
cells (IECs) play an important role in immune homeostasis (4,5). IECs are thought to contribute 76 
to immunomodulation of mucosal leucocytes by at least two different mechanisms (6), by 77 
acting as a physical barrier between gut luminal content (including bacteria) and the 78 
underlying immune cells, and by transmitting signals coming from the intestinal content and 79 
microbiota to the resident mucosal immune system (4). IECs secrete many mediators involved 80 
in protective responses against potentially pathogenic organisms, such as defensins, mucins, 81 
chemokines and cytokines (5).   82 
Bifidobacteria, which are important components of the human intestinal microbiota 83 
particularly of breast-fed infants (7), have shown capacity to modulate cytokine production by 84 
IECs, monocyte derived dendritic cells and peripheral blood mononuclear cells (PBMCs) in 85 
in vitro experiments (1,8,9). In addition, the differences observed in the composition of 86 
bifidobacterial species of the intestinal microbiota of breast-fed (BF) and formula-fed (FF) 87 
infants have been suggested to influence the incidence of immune-mediated diseases (7,10). 88 
These findings have led to propose the use of some Bifidobacterium strains as potential 89 
probiotics in the prevention and treatment of pathologies with underlying immune alterations, 90 
such as inflammatory bowel diseases, allergy and celiac disease (11-13).   91 
Following all of the aforementioned facts and hypothesis, the objective of this study 92 
was to investigate the effect of strains of different bifidobacterial species (Bifidobacterium 93 
adolescentis; Bifidobacterium angulatum; Bifidobacterium breve; Bifidobacterium 94 
catenulatum; Bifidobacterium infantis; Bifidobacterium longum) and mixtures of them, 95 
corresponding to the typical microbiota present in feces from BF and FF children, on the 96 
modulation of the cytokine production by IECs and PBMCs in an in vitro co-culture system, 97 
simulating the intestinal environment . 98 
 99 
 100 
 101 
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Materials and methods 102 
 103 
Bacteria 104 
 105 
The following strains of six different Bifidobacterium species were individually evaluated: B. 106 
adolescentis ATCC 15703, B. angulatum ATCC 27535, B. breve ATCC 15700, B. 107 
catenulatum LMG 11043, B. longum biovar infantis LMG 11046T and B. longum biovar 108 
longum ATCC 15707. B. adolescentis ATCC 15703, B. angulatum ATCC 27535, B. breve 109 
ATCC 15700, B. catenulatum LMG 11043, B. longum biovar infantis LMG 11046T and B. 110 
longum biovar longum ATCC 15707. In addition, two combinations of these bifidobacteria 111 
were also used to simulated the percentage of each species in the microbiota from breast-fed 112 
(BF) and formula-fed (FF) infants (10). The BF mixture included: B. infantis (59·0%), B. 113 
breve (21·6%), B. longum (13·5%), B. catenulatum (3·5%), B. angulatum (1·8%) and B. 114 
adolescentis (0·6%); and the FF mixture included: B. infantis (62·1%), B. catenulatum 115 
(14·8%), B. longum (10·9%), B. breve (7·2%), B. adolescentis (5·0%) (no B. angulatum). 116 
Bifidobacteria were grown routinely in MRS agar (Scharlau Chemie SA, Barcelona, 117 
Spain) with 0.05% cysteine broth and incubated at 37°C under anaerobic conditions 118 
(AnaeroGen, Oxoid, Basingstoke, UK) for 22 h. Cells were harvested by centrifugation (6000 119 
g for 15 min) till stationary growth phase, washed two times in PBS (130 mM sodium 120 
chloride, 10 mM sodium phosphate, pH 7.4, and resuspended in PBS containing 20% 121 
glycerol). Aliquots of these suspensions were frozen in liquid nitrogen and stored at –80°C 122 
until used. The number of live cells after storage was determined by CFU counting on MRS-C 123 
after 48 h incubation in optimal conditions. For all strains tested, >90% cells were alive upon 124 
thawing. One fresh aliquot was thawed for every new experiment to avoid variability in the 125 
cultures between experiments. 126 
 127 
Leukocyte isolation and bacterial stimulation of PBMCs 128 
 129 
Human peripheral blood mononuclear cells (PBMCs) from 7 healthy volunteers were isolated 130 
from heparinised blood samples using standard Ficoll gradient centrifugation (Lymphocyte 131 
isolation solution, Rafer, Spain). Separated PBMCs were washed twice with RPMI-1640 132 
medium (Bio-Whittaker, Verviers, Belgium) and suspended in the same medium, 133 
supplemented with heat-inactivated fetal bovine serum (FBS) (100 ml/l) (BioWhittaker®), 134 
after decomplementation, and containing 1% penicillin/streptomycin (P/S) (5000 IU/ml, 5000 135 
 
 
5 
 
mg/ml) (BioWhittaker®). PBMC suspension was adjusted to 2 x 106 cells/ml, and 1 x 106 cells 136 
were used per well in all experiments.  137 
Live bacterial cell suspensions of each individual Bifidobacterium strain or the 138 
combinations representing the fecal microbiota composition of the BF and FF infants were 139 
washed in culture medium and incubated at a final concentration of 107 cfu/mL with PBMCs 140 
(proportion bacteria:PBMC, 10:1) during 48 hours (5% CO2, 37ºC). The supernatant was 141 
collected, centrifuged and frozen in aliquots at -80ºC until cytokine analysis. 142 
 143 
Coculture Caco-2/PBMC and bacterial stimulation  144 
 145 
The colonic adenocarcinoma cell line Caco-2 (ECACC Nº 86010202, Salisbury, UK) was 146 
cultured at 37ºC and 5% CO2 in EMEN medium (BioWhittaker®) supplemented with 10% 147 
FBS (BioWhittaker®), 1% non-essential amino acid solution (NAA) (BioWhittaker®), 1% L-148 
Glutamine (BioWhittaker®) and 1% P/S (BioWhittaker®). Caco-2 cells were seeded at a 149 
density of 8 x 104 cells/well in standard 24-well culture plates, and at 4 x 104 cells/well on 12 150 
mm inserts in 24-well cell culture plate assemblies (Millipore) with a semipermeable 151 
polyethylene terepfthalate membrane (PTE; 1 μm pore size). During cell growth and 152 
differentiation, medium was changed every two or three days. The experiments were 153 
performed 10-11 days after seeding, once the cells were confluent and differentiated. 154 
Confluence was followed with microscopic visualization and TER measurements (Millicell 155 
ERS Ohmmeter, Millipore, Madrid, Spain). 156 
Cocultures of the bifidobacteria with Caco-2 cells and PBMCs from healthy donors 157 
were performed in 7 different experiments. To that end, a transwell cell culture system was 158 
used as described above. Caco-2 monolayers were challenged by apical addition of 2 x 106 159 
cfu/insert of a Bifidobacterium strain or a combination of strains corresponding to the species 160 
composition in fecal samples from BF and FF infants. 500 µL of a PBMCs suspension was 161 
added at a concentration of 2 x 106 cells/mL in the basal compartment of the culture well for a 162 
12-hour incubation. Thereafter, further 36-hour incubation was allowed after disassembly of 163 
the system. In order to measure the cytokine production by the sensitised Caco-2 and PBMCs 164 
separately, the basolateral compartment of the Caco-2 cells was replenished with fresh culture 165 
medium. After the incubation period, culture media, both from the separated PBMC and 166 
Caco-2 cell plates, were collected and frozen in aliquots at -80ºC. PBMCs supernatant was 167 
centrifuged prior to freezing to avoid cell presence in aliquots.  168 
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Two more conditions, which served as a control of the Caco-2 cell conditioning by the 169 
underlying PBMCs, were carried out in two different wells: mixture BF and mixture FF were 170 
added to Caco-2 monolayers in transwells with no PBMCs in the basal compartment. 171 
 172 
Cytokine quantification in culture supernatants 173 
 174 
TNF-α, IL-1β, IL-10, IL-8 and IL-6 cytokines were measured in Caco-2 cells’ basolateral 175 
medium, and TNF-α, IFN-γ, IL-6, IL-10, IL-2 and IL-4 were measured in the PBMCs 176 
supernatant. All cytokines were performed by Cytometric Bead Array System (CBA, BD 177 
Biosciencies; Inflammation Kit and either Th1/Th2 kit or Flex set), according to the 178 
manufacturer’s protocols, and analyzed by flow cytometry (FACScalibur, BD Biosciencies). 179 
Data were analyzed using Cellquest software (BD Biosciencies). CBA limit  of detection for 180 
each cytokine was: IFN-γ: 7·1 pg/ml; TNF-α: 2·8 pg/ml; IL-10: 0·13 pg/ml; IL-6: 1·6 pg/ml; 181 
IL-8: 1·2 pg/ml; IL-4: 2·6 pg/ml; IL-2: 2·6 pg/ml; IL-1β: 7·2 pg/ml. IFN-γ was also measured 182 
with high sensitivity Immunoassay xMAP Technology (Millipore, Spain) in a Luminex 100 183 
equipment, with a sensitivity of 0·29 pg/ml. 184 
 185 
Statistical analyses 186 
 187 
Statistical analyses were performed using SPSS version 17.0 software (SPSS Inc., Chicago, 188 
IL, USA). To establish the homogeneity of variances and the distribution of the data, the 189 
Levene test was run. As a result of the non-normal distribution of the data and the non-190 
homogeneity of the variances, Mann-Whitney U test was used to assess the effect of every 191 
experimental condition compared to the other conditions. Data are expressed as medians and 192 
quartiles. Significant differences were established at P < 0·05. Correlations between different 193 
bacterial stimulatory conditions were analysed by Spearman’s correlation test and considered 194 
significant at a P level < 0·05. 195 
 196 
 197 
 198 
 199 
 200 
 201 
 
 
7 
 
Results 202 
 203 
1) Cytokine production by PBMCs cultured with bifidobacteria 204 
 205 
In order to determine the immunological effect of bifidobacteria on PBMCs, the production of 206 
IFN-γ, TNF-α, IL-10, IL-6, IL-4 and IL-2 was measured in the supernatants of PBMCs 207 
cultured in direct contact with the different Bifidobacterium strains (individually or mixed). 208 
Among all cytokines analysed, only IL-2 was not stimulated (Table 1 and Fig. 1A), with 209 
levels below 20 pg/ml (except for the positive control with PHA; data not shown). All the 210 
other cytokines were significantly stimulated by all bifidobacterium species and mixtures 211 
(compared with the control with only medium). 212 
Regarding IFN-γ production (Table 1 and Fig. 1B), B. catenulatum and B. breve were 213 
the strongest enhancers, followed by FF and BF mixtures (no significant differences were 214 
found between both mixtures). B. catenulatum induced a higher IFN-γ production than all the 215 
other stimuli (except for B. breve). B. breve induced a higher IFN-γ production than B. 216 
adolescentis, B. angulatum and B, infantis, but similar to that induced by B. catenulatum, B. 217 
longum and the mixtures. The total percentage of B. catenulatum and B. breve was similar in 218 
FF and BF mixtures, (22·05% and 25·12%, respectively). This might explain that the levels of 219 
IFN-γ produced by PBMCs stimulated with FF and BF mixtures were not statistically 220 
different. 221 
B. longum and B. catenulatum induced the highest IL-10 production by PBMCs, 222 
showing significant differences with IL-10 production in the presence of B. infantis and the 223 
BF mixture (Table 1 and Fig. 1C). B. longum IL-10-induced production was also significantly 224 
higher than that of B. angulatum, B. breve and the FF mixture. The percentages of B. longum 225 
in FF and BF mixtures were very similar (10·87% vs 13·52%), but B. catenulatum was 226 
approximately four times higher in FF than BF (14·84% vs 3·50%).  The low proportion of B. 227 
catenulatum and B. adolescentis, together with the high proportion of B. infantis and B. breve 228 
in the BF mixture, might explain the significantly lower production of IL-10 induced by the 229 
BF mixture compared to that induced by B. adolescentis, B. catenulatum, and B. longum 230 
individually (Table 1 and Fig. 1C). Regarding IL-4, B. catenulatum also induced a 231 
significantly higher production than B. adolescentis and B. infantis (Table 1 and Fig. 1D). 232 
All Bifidobacterium strains stimulated PBMCs to produce very high levels of IL-6, 233 
over  4000 pg/ml (Table 1 and Fig. 1E). B. adolescentis induced the highest IL-6 production; 234 
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significantly higher than B. angulatum, B. breve and B. infantis (P=0·029 in every case). B. 235 
infantis induced the lowest effect among the assayed strains on cytokine production, not only 236 
for IL-6, but also for IFN-γ, IL-10 and IL-4. 237 
With the exception of B. adolescentis, all Bifidobacterium strains also stimulated 238 
PBMCs to produce very high levels of TNF-α (Table 1 and Fig. 1F). A significantly higher 239 
TNF-α production was induced by B. angulatum and B. catenulatum compared to B. 240 
adolescentis, B. breve and B. longum.  While B. longum and B. adolescentis induced a high 241 
production of IL-10, they both mildly induced TNF-α (Table 1 and Figs. 1C/F). On the other 242 
hand, while B. infantis and B. angulatum induced a mild production of IL-10, they both 243 
highly induced TNF-α (Table 1 and Figs. 1C/F). 244 
 245 
2) Cytokine production by PBMCs in coculture with Caco-2 cells and bifidobacteria 246 
 247 
To analyze cytokine production by PBMCs conditioned by previous co-culture with Caco-2 248 
cells stimulated with bifidobacteria, IFN-γ, TNF-α, IL-10, IL-6, IL-4 and IL-2 were measured 249 
in PBMCs supernatants. IL-2 and IL-4 were not detectable and TNF-α was also below the 250 
limit or approaching the limit of detection (data not shown). No significant differences in IL-251 
10 and IL-6 production were found, either between different bifidobacteria alone or in 252 
mixtures (Table 2 and Figs. 2A/B). 253 
The production of IFN-γ by PBMCs was low in this system (range: 1-93 pg/mL and 254 
under the detection limit in 2 of 7 PBMCs donors). Using the available data from the other 5 255 
donors, we found induction of IFN-γ production by BF mixture in 4 of them (>100% vs 256 
control) and in 3 of them also with B. breve (>50% vs. control), which is singularly high in 257 
the BF combination. Moreover, 3 donors showed stimulation with FF (>100% vs. control). 258 
BF mixture was the stimulus that induced the highest IFN-γ production (Table 2 and Fig. 2C), 259 
significantly higher than B. adolescentis (P=0·014), B. infantis (P=0·050) and B. longum 260 
(P=0·047) individually. Although B. breve also induced the production of IFN-γ, this effect 261 
was not significantly different from the other bifidobacteria (Table 2 and Fig. 2C). B. 262 
adolescentis’ effect on IFN-γ induction was inhibitory relative to the control condition and 263 
was significantly different from the stimulatory effect observed with the bifidobacteria 264 
mixtures and B. longum (Table 2 and Fig. 2C). 265 
 266 
 267 
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3) Cytokine production by Caco-2 cells in coculture with PBMCs and bifidobacteria 268 
 269 
To assess the effects of bifidobacteria and bifidobacteria mixtures stimulation on Caco-2 cells 270 
in coculture with PBMCs, TNF-α, IL-1β, IL-10, IL-8 and IL-6 cytokines were measured in 271 
both apical and basolateral mediums. All cytokines were not detectable in the apical medium, 272 
while in the basolateral medium only IL-8 and IL-6 were in a measurable concentration range 273 
(IL8: 120-14000 pg/mL; IL6: 30-600 pg/mL). When Caco-2 cells were stimulated with the 274 
bifidobacteria alone, with no PBMCs in the underlying compartment the stimulation of both 275 
cytokines was 3 to 4 times lower than in the coculture system (data not shown). 276 
When in coculture with PBMCs, B. breve highly stimulated the production of IL-6 and 277 
IL-8 on Caco-2 cells (66·8% and 45·5%, respectively) (Table 3 and Figs. 3A/B). For IL-8, this 278 
production was significantly higher, compared with B. adolescentis (P=0·035), B. infantis 279 
(P=0·025) and FF mixture (P=0·013) (Table 3 and Fig. 3B). Although BF mixture also 280 
induced IL-6 and IL-8 production (36·0% and 20·7%, respectively), these values were not 281 
significantly higher than those induced by the FF mixture (Table 3 and Fig. 3A/B). No 282 
significant differences were observed for IL-6 production between the different stimuli 283 
assayed (Table 3 and Fig. 3A). 284 
Considering the PBMCs donors individually, IL-8 and IL-6 production stimulated by 285 
the FF mixture was positively and significantly correlated with IL-8 and IL-6 production 286 
stimulated by B. infantis (P<0·001 for both cytokines). On the other hand, IL-8 production 287 
stimulated by BF mixture was correlated with B. angulatum, B. breve and B. catenulatum 288 
(P<0·05), and IL-6 stimulated by BF mixture correlated with B. adolescentis and B. 289 
catenulatum (P<0·05). 290 
 291 
Discussion 292 
 293 
Bifidobacterium strains have shown capacity to modulate cytokine production by intestinal 294 
epithelial cells, monocyte derived dendritic cells and peripheral blood mononuclear cells 295 
(PBMC) in in vitro experiments (1,8,9). Trying to define this immunomodulatory capacity 296 
seems relevant in order to understand their contribution to the establishment of mucosal 297 
tolerance and balanced intestinal immune responses in the early stages of of life. Both these 298 
processes have been linked to the prevention of immune-mediated disorders later in life, such 299 
as allergies or inflammatory bowel disease (14,15).  Several studies have evaluated the effect of 300 
different bifidobacteria in the production of cytokines by Caco-2 cells and PBMCs (6,9,16-18) 301 
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but according to our knowledge, this is the first time that the Bifidobacterium strains used in 302 
the present work have been employed in coculture experiments and the first time that the 303 
mixtures in the proportions of a formula fed and breast fed infant typical microbiota have 304 
been used to stimulate these cell types.  305 
In the present study, the levels of several cytokines were measured in two different 306 
systems: 1) a direct stimulation of PBMCs with bifidobacteria and 2) a PBMCs/Caco-2 cells 307 
co-culture with bifidobacteria stimulating the top layer of Caco-2 cells, which, in turn, can 308 
interact with underlying PBMCs through soluble mediators. Reciprocally, PBMCs are able to 309 
influence Caco-2 cell activity as well. The profile of cytokine production by PBMC exposed 310 
directly to the Bifidobacterium strains shows relevant differences compared with the profile of 311 
cytokine production by PBMCs in the coculture system, where Caco-2 cells constitute a 312 
physical barrier preventing PBMCs’ access to the bifidobacteria. The first differential finding 313 
is that the level of cytokine production is much lower in the co-culture system. For instance, 314 
while 3 out of 6 cytokines measured were above 1000 pg/mL when both bifidobacterial 315 
mixtures where used, and 2 out of the remaining 3 gave results higher than 100 pg/mL in 316 
direct contact, only IL-6 by PBMCs in the coculture system  gave results higher than 1000 317 
pg/mL. It is worth noting that while in the direct contact, IL-6 and TNF-α were the cytokines 318 
most highly induced, in the coculture system not only IL-6 but also IL-10 were the cytokines 319 
most highly produced by PBMCs. In this sense, Niers et al. (2005) showed in a single culture 320 
system that the production of IL-10 by PBMCs is boosted by several Bifidobacterium strains 321 
and this down-regulates the production of TNF-α and IL-12p70 by these cells. When they 322 
used a monoclonal antibody against IL-10, they found a huge increase in the production of 323 
these inflammatory cytokines. 324 
Different cytokines (IL-8 and IL-6) were also stimulated on Caco-2 cells, but only 325 
when they were previously co-cultured with PBMCs; no cytokine production was measured if 326 
the Caco-2 cells were cultured alone with the Bifidobacterium strains. Therefore, the presence 327 
of PBMCs is an essential factor for the sensitization of Caco-2 cells to respond to 328 
bifidobacteria, which is presumably exerted by the communication between both cell types 329 
through soluble mediators. In this and other studies Caco-2 cells alone were found to be 330 
hyporesponsive to bifidobacteria stimulation (19) and also to other probiotic bacteria (18,19). 331 
Moreover, since cytokine production by Caco-2 cells in the coculture system was only 332 
detectable in the basolateral medium and not in the apical one, it demonstrates a polarised 333 
secretion by Caco-2 cells, as other authors have found before (18). In a similar co-culture 334 
system, in which Caco-2 cells  were stimulated with non-pathogenic E. coli and L. sakei, an 335 
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induction of  TNF-α secretion to the subepithelial compartment was observed and this 336 
cytokine was signalled as the fundamental candidate for cellular cross talk (18). In contrast, we 337 
found no detectable production of TNF-α, which might be explained by a differential effect 338 
from different bacterial species and strains. 339 
Regarding the immunomodulatory effects of specific strains used in these 340 
experiments, the most relevant findings have been found regarding the immunostimulatory 341 
effects of B. breve. This strain stimulated most the production of IL-8 and IL-6 on both Caco-342 
2 and PBMC cells. In the microbiota of breast-fed infants, B. breve is the most representative 343 
Bifidobacterium species (after B. infantis, common in all milk fed babies), and this could 344 
explain the high IL-8 and IL-6 levels produced by Caco-2 and PBMC stimulated with BF 345 
mixture. This link between B. breve and BF mixture was supported by the correlation found 346 
between IL-8 levels produced by Caco-2 cells stimulated by B. breve and BF mixture. 347 
Moreover, B. breve and BF mixture also stimulated the production of IL-10 and INF-γ by 348 
PBMCs (in coculture with Caco-2 cells). All these observations might indicate that the 349 
proportion of different Bifidobacterium species is an important determinant of the overall 350 
contribution to the stimulation of cytokines on the intestinal mucosa. In this sense, it is 351 
interesting to note that there was a correlation between the relative inhibition of IL-8 352 
production by Caco-2 cells induced by the FF mixture and by B. infantis. It seems that the 353 
differences in the proportions of the different strains between the mixtures and the 354 
stimulatory/inhibitory capacities shown by the individual strains might explain the results 355 
found with their combinations in the BF and FF mixtures. 356 
According to the results, B. breve induced a slight pro-inflammatory response, which 357 
could turn the mucosal immune system on stand-by and prevent the release of a severe 358 
inflammation. It has been already reported that infants from 4 to 6 months old, who 359 
daily consumed infant formula fermented with B. breve and Streptococcus thermophilus, 360 
presented less severe episodes of acute diarrhea than the standard formula group (20). 361 
Furthermore, Li and collaborators showed that the administration of B. breve to low birth 362 
weight infants was useful in promoting the colonization by other bifidobacteria, which might 363 
contribute to the establishment of a healthier microbiota  (21). More recently, it has been found 364 
that the administration of B. breve to preterm infants can up-regulate TGF-β1 signaling and 365 
may possibly be beneficial in attenuating inflammatory and allergic reactions in these infants 366 
(22).  367 
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Regarding the stimulation of the regulatory cytokine IL-10 by PBMCs after direct 368 
stimulation with B.longum, similar finding have been previously described by Medina et al. 369 
(2007), who found that several strains of B. longum are strong inducers of IL-10 secretion on 370 
PBMCs. On the other hand, the finding that B. infantis is a weak inducer of cytokine secretion 371 
after direct stimulation of both, PBMCs and Caco-2 cells, is in agreement with prior published 372 
results that have described that B. infantis attenuates baseline IL-8 secretion in HT-29 373 
epithelial cells (5) as well as proinflammatory IL-17 production by murine splenocytes and 374 
dextran sodium sulphate-induced intestinal inflammation (23,24).  375 
In conclusion, among the Bifidobacterium species tested, B. breve seems to be the 376 
most immunostimulatory strain in a co-culture system resembling the physiological layout of 377 
different cell types in the intestinal mucosa. The presence and relative proportions of different 378 
Bifidobacterium species in the microbiota of breast fed and formula fed infants could be key 379 
factors defining the immunomodulatory effect of the gut microbiota in early life.  380 
 381 
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Fig. 1. Cytokine production by PBMCs after 48h incubation with individual bifidobacterium strains and their mixtures (BF and 
FF) in a 10:1 (bacteria:cell) ratio. Each box represent median (50th percentile) and interquartile range (25th and 75th percentiles). 
Asterisks and dots represent outliers and extreme values, respectively. Different letters mean statistically significant differences. 
Mann-Whitney U test. P<0·05. No differences were observed in IL-2 production between conditions. 
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Fig. 2. Cytokine production in a 48-hour culture of PBMCs sensitized by a 12h-incubation in a transwell co-
culture system with CaCO-2 cells apically stimulated with bifidobacteria. Values are given as percentage of 
the control (spontaneous production with no added bacteria). Each box represent median (50th percentile) 
and interquartile range (25th and 75th percentiles). Asterisks and dots represent outliers and extreme values, 
respectively. Different letters mean statistically significant differences. Mann-Whitney U test. P<0·05. No 
differences were observed in IL-10 and IL-6 production between the different bifidobacterium conditions 
employed; however, LPS stimulated production was always significantly higher than the rest of conditions. 
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Fig. 3. Bifidobacteria-stimulated cytokine production by Caco-2 cells in a 36-hour culture (basolateral 
medium) following prior 12h-sensitization with PBMCs in a transwell co-culture system. Values are 
given as percentage of the control (spontaneous production with no added bacteria). Each box 
represent median (50th percentile) and interquartile range (25th and 75th percentiles). Asterisks and 
dots represent outliers and extreme values, respectively. Different letters mean statistically significant 
differences. Mann-Whitney U test. P<0·05. No differences were observed in IL-6 production between 
conditions. 
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         Table 1. Cytokine production by PBMCs cultured with the bifidobacteria. 
 
Different superscript letters mean statistically significant differences· Mann-Whitney U test. P<0·05. 
BF: breast fed; FF: formula fed. 
   
Cytokine (pg/ml) 
Stimuli IL-2 IFN-γ IL-10 IL-4 IL-6 TNF-α 
B. adolescentis     
Median 9·95 230·28a 422·06acf 610·44a 7723·24a 1656·45a 
Minimum 9·02 103·34 361·72 579·27 7515·53 1520·79 
Maximum 16·94 326·72 591·26 663·11 7840·63 1660·91 
B. angulatum       
Median 9·35 329·61a 301·70cdg 731·17acdf 6848·16bc 8735·21b 
Minimum 7·96 316·58 138·39 659·16 6145·95 7652·71 
Maximum 11·98 348·84 492·82 867·62 7332·61 10162·08 
B. breve       
Median 11·40 1912·91bc 211·40bcdg 682·70bcd 6973·64bd 6160·78cd 
Minimum 8·48 922·97 99·19 673·93 6536·60 5653·84 
Maximum 15·13 2598·70 464·38 748·79 7488·86 7193·55 
B. catenulatum       
Median 11·60 3292·41b 614·68adf 772·46bcf 7525·74abd 9030·84b 
Minimum 10·30 2401·38 384·15 733·33 6939·44 8338·47 
Maximum 14·41 7392·18 1251·51 893·34 7827·05 10418·59 
B. infantis       
Median 10·02 100·43a 52·38beg 591·48ad 4490·01c 6891·72bcd
Minimum 7·65 80·38 20·17 498·56 3801·96 5151·38 
Maximum 11·60 390·78 104·47 692·46 6474·54 9737·87 
B. longum       
Median 11·26 774·78c 1019·33f 725·83abcd 7770·10ad 4722·53c 
Minimum 10·41 608·80 528·01 659·14 7470·63 3520·22
Maximum 12·20 1291·65 1587·53 767·42 8191·40 6135·92 
BF combination       
Median 10·40 1204·56c 141·26bg 689·54abcdf 6446·27abcd 7677·01bcd 
Minimum 10·07 675·42 57·70 566·37 5387·99 5640·80 
Maximum 11·93 2073·37 311·39 817·92 7590·74 9865·33 
FF combination       
Median 10·02 1316·86c 211·71aceg 733·19abcdf 6766·16abcd 8032·24bd 
Minimum 9·02 1068·30 103·45 644·90 6286·95 6296·63 
Maximum 11·78 2020·49 435·16 836·95 7815·05 9958·65 
Control       
Median 13·60 60·40d 4·87h 8·57e 10·51e 3·27e 
Minimum 8·79 55·79 3·71 6·14 7·49 1·88 
Maximum 16·82 67·65 6·38 10·90 19·11 4·15 
LPS       
Median 12·06 360·71a 627·62acdf 804·01f 7920·60a 1789·52a 
Minimum 10·37 141·79 329·47 777·99 7509·36 599·38 
Maximum 15·66 553·15 737·32 833·66 8158·12 2183·25 
Table 2. Cytokine production by PBMCs in co-culture with CaCO-2 cells and bifidobacteria. 
 
 
 
 
 
*Cytokine production presented as percentage of the control (spontaneous 
production in the co-culture without bifidobacteria). 
Different superscript letters mean statistically significant differences. Mann-
Whitney U test. P<0·05. BF: breast fed; FF: formula fed. 
 
 
Cytokine (%)* 
Stimuli IL-6 IL-10 IFN-γ 
B. adolescentis    
Median 6·36 1·56 -28·76a 
Minimum -93·00 -57·20 -100·00 
Maximum 9·29 69·74 8·33 
B. angulatum    
Median 4·92 -17·77 50·13abc 
Minimum -85·18 -62·76 -63·47 
Maximum 6·90 52·10 87·66 
B. breve    
Median 3·40 21·40 106·50abc 
Minimum -35·26 -80·06 -23·63 
Maximum 900·00 207·28 305·20 
B. catenulatum    
Median 0·85 9·79 4·11abc 
Minimum -53·98 -62·13 -10·33 
Maximum 207·01 139·51 261·91 
B. infantis    
Median 6·30 1·65 19·91abd 
Minimum -86·75 -56·60 -87·30 
Maximum 525·32 670·52 54·51 
B. longum    
Median -0·33 -4·93 28·57bd 
Minimum -88·96 -47·41 -12·57 
Maximum 7·11 188·64 96·19 
BF combination    
Median 5·92 7·31 120·14c 
Minimum -52·77 -30·89 25·78 
Maximum 600·00 600·00 651·50 
FF combination    
Median 1·52 2·55 114·93bc 
Minimum -92·94 -98·83 -40·12 
Maximum 750·00 190·03 572·79 
LPS    
Median 2·55 1161·25 59·28cd 
Minimum -0·12 85·80 9·57 
Maximum 5000·00 2000·00 913·30 
Table 3. Cytokine production by CaCO-2 cells in co-culture with PBMCs and bifidobacteria. 
 
 
* Cytokine production presented as percentage of the control (spontaneous 
production in the co-culture without bifidobacteria). 
Different superscript letters mean statistically significant differences. Mann-
Whitney U test. P<0·05. BF: breast fed; FF: formula fed. 
 
Cytokine (%)* 
Stimuli IL-6 IL-8 
B. adolescentis   
Median 30·95 -9·97a 
Minimum -58·67 -42·07 
Maximum 388·74 331·73 
B. angulatum 
Median 44·87 -0·35ab 
Minimum -47·91 -42·42 
Maximum 335·53 310·10 
B. breve   
Median 66·83 45·52bc 
Minimum 6·80 -2·02 
Maximum 343·81 411·06 
B. catenulatum   
Median 32·36 3·38ab 
Minimum -48·50 -37·90 
Maximum 288·32 588·94 
B. infantis   
Median -43·60 -16·35a 
Minimum -68·78 -76·92 
Maximum 148·92 21·75 
B.longum 
Median 115·96 5·22ab 
Minimum -30·66 -29·73 
Maximum 132·98 132·21 
BF combination   
Median 36·01 20·67ab 
Minimum -38·09 -59·27 
Maximum 226·18 961·54 
FF combination   
Median -21·75 -6·81a 
Minimum -57·14 -64·90 
Maximum 55·13 44·58 
LPS   
Median 266·20 132·24c 
Minimum -28·51 14·26 
Maximum 719·61 1000·00 
